Why Most Peptides Need a Needle

Peptides are chains of amino acids, and the digestive system is built to take chains of amino acids apart. That is its job. A peptide meant to act as a signal faces the same machinery that handles dinner.

Three obstacles

1. Acid. Stomach acid can change a peptide's shape and break some bonds.
2. Enzymes. Pepsin in the stomach, then trypsin, chymotrypsin and others in the small intestine, cut peptide bonds. Brush-border enzymes finish the work.
3. The wall. The intestinal lining is selective. Large, charged, water-loving molecules cross it poorly, and peptides are often all three.

The result is that oral bioavailability of ordinary peptides is typically very low, often a few percent at best and frequently much less.

How oral versions exist at all

Oral semaglutide is the best-known case. It is a GLP-1 receptor agonist taken as a tablet that contains an absorption enhancer called SNAC. The tablet is designed to act in the stomach, locally raising pH around the dose and helping the peptide cross the stomach lining. Its absorption is still small and variable, which is why the label requires specific conditions, such as taking it on an empty stomach with a limited amount of water.

Other approaches under study include protective coatings, enzyme inhibitors, and chemical changes that make a peptide harder to cut.

Why injection remains common

Injecting under the skin bypasses the gut completely and gives more predictable exposure. That predictability is the main reason most peptide medicines are delivered that way.

A caution on marketing

"Oral peptide" products sold as supplements rarely come with human absorption data. Absence of evidence is not evidence of absorption. A paper showing uptake of a specially formulated drug does not transfer to a different molecule in a capsule.